You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

29 September 2017

Disagreement over best treatment regimes for pregnant women with HIV

A BMJ international panel made up of women living with HIV, specialist doctors, and general practitioners recommends non-tenofovir based treatment regimes for pregnant women living with HIV.

0
27 September 2017

Talking HIV: New series shares real-life experiences of people living with HIV

In Avert’s revealing new podcast series we hear from people whose lives have been affected by HIV. 

0
26 September 2017

New research casts doubt on age gap theory of HIV transmission

Research from South Africa suggests a women’s HIV risk may be driven more by their male partner’s age rather than the age gap between them.

0
20 September 2017

PrEP trial for adolescents: a promising step forward for HIV prevention

A US trial among 15 to 17 year-old men who have sex with men (MSM) suggests this group stands to benefit hugely should pre-exposure prophylaxis (PrEP) be approved – and supported – for this age group. 

0
18 September 2017

Predicting tuberculosis: how a simple score card could hold the key to more effective TB prevention

A new low-cost, low-tech method for predicting an adult’s risk of developing tuberculosis (TB) could represent a major step forward for TB prevention.

0
15 September 2017

HIV and cancer in the age of ART

Although the risk of developing cancer is decreasing for people living with HIV as antiretroviral treatment (ART) improves, it remains higher for certain cancers – and as ART expands, this burden is expected to grow.

0
13 September 2017

Most HIV-positive migrants in Europe acquired HIV post-migration

The majority of migrants living with HIV in Europe became infected after arriving to their new country – debunking the previously held assumption that HIV infections among migrants are imported.

0
08 September 2017

HIV funding cutbacks: severe health outcomes for minimal financial gains

Savings would be ‘small and transient’ – raising significant ethical and efficacy concerns about the benefit of US budget cuts for HIV programming abroad. 

0
06 September 2017

Getting people testing for HIV and into care in China

Landmark Lancet study shows the benefit of a simplified approach to HIV testing, diagnosis and linking to care for people living with HIV in a middle-income country.

0
04 September 2017

The HIV ‘failure cascade’: low-resourced settings and the last ‘90’

HIV programmes must develop strategies and allocate resources for people who enter the ‘failure care cascade’ – or risk jeopardising the important gains already made on HIV treatment.

0